Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Phase 3

Completed

• Conditions: Keratoconjunctivitis Sicca; Sjogren's Syndrome; Lupus Erythematosus, Systemic; Arthritis, Rheumatoid; Scleroderma, Systemic

• Registration Number: NCT00025818
• Lead Sponsor: Allergan

Brief Summary

A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-05
• Study First Submitted: 2001-10-26
• Study First Submitted QC: 2001-10-26
• Study First Posted: 2001-10-29
• Primary Completion: 2003-03
• Study Completion: 2003-03
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-27
• Last Update Posted: 2011-05-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 290

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (17)

Eyecare of La Jolla; 🇺🇸 La Jolla, California, United States

UCLA; 🇺🇸 Los Angeles, California, United States

Opticare; 🇺🇸 Waterbury, Connecticut, United States

Brandon Eye Clinic; 🇺🇸 Tampa, Florida, United States

Emory University; 🇺🇸 Atlanta, Georgia, United States

UIC Eye Center; 🇺🇸 Chicago, Illinois, United States

Indiana University; 🇺🇸 Indianapolis, Indiana, United States

Hunkleler Eye Center; 🇺🇸 Overland Park, Kansas, United States

D'Ambrosio Eye Care; 🇺🇸 Leominster, Massachusetts, United States

Great Lakes Eye Institute; 🇺🇸 Saginaw, Michigan, United States

Scroll for more (7 remaining)